News Releases

Feb 24, 2021
SHANGHAI and GAITHERSBURG, Md. , Feb. 24, 2021 /PRNewswire/ --  I-Mab (the "Company") (Nasdaq: IMAB ), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in
Displaying 51 - 59 of 59